Annual Net Margin
N/A
01 December 2023
Summary:
Plus Therapeutics annual net profit margin is not available.PSTV Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
N/A
01 September 2024
Summary:
Plus Therapeutics quarterly net profit margin is not available.PSTV Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV Net Margin Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | - | - |
5 y5 years | - | - |
PSTV Net Margin High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time |
Plus Therapeutics Net Margin History
Date | Annual | Quarterly |
---|---|---|
Dec 2020 | -2719.80%(+1648.3%) | - |
June 2020 | - | -994.05%(+7.9%) |
Mar 2020 | - | -921.19%(-1338.0%) |
Dec 2019 | -155.57%(-63.3%) | 74.41%(+575.2%) |
Sept 2019 | - | 11.02%(-102.6%) |
Mar 2019 | - | -427.41%(+470.2%) |
Dec 2018 | -423.53%(+19.7%) | -74.96%(-68.1%) |
June 2018 | - | -234.70%(-12.3%) |
Mar 2018 | - | -267.54%(-4.6%) |
Dec 2017 | -353.86%(+82.7%) | -280.56%(+3.5%) |
Sept 2017 | - | -271.12%(-32.8%) |
June 2017 | - | -403.27%(-14.0%) |
Mar 2017 | - | -468.86%(+188.5%) |
Dec 2016 | -193.73%(+20.5%) | -162.50%(-21.2%) |
Sept 2016 | - | -206.28%(-9.0%) |
June 2016 | - | -226.73%(+23.9%) |
Mar 2016 | - | -182.97%(+123.6%) |
Dec 2015 | -160.77%(-67.3%) | -81.84%(-232.7%) |
Sept 2015 | - | 61.65%(-106.6%) |
Mar 2015 | - | -935.98%(+512.9%) |
Dec 2014 | -491.81%(+129.1%) | -152.72%(-82.1%) |
Sept 2014 | - | -850.86%(-7.1%) |
June 2014 | - | -916.19%(+26.3%) |
Mar 2014 | - | -725.24%(+149.9%) |
Dec 2013 | -214.64%(-3.6%) | -290.17%(+49.6%) |
Sept 2013 | - | -193.95%(+36.9%) |
June 2013 | - | -141.64%(-30.6%) |
Mar 2013 | - | -204.02%(+290.8%) |
Dec 2012 | -222.60%(-31.4%) | -52.20%(-93.9%) |
Sept 2012 | - | -854.71%(+374.5%) |
June 2012 | - | -180.14%(-71.3%) |
Mar 2012 | - | -628.37%(+158.2%) |
Dec 2011 | -324.64%(+25.5%) | -243.38%(-37.5%) |
Sept 2011 | - | -389.67%(+83.7%) |
June 2011 | - | -212.14%(-54.4%) |
Mar 2011 | - | -464.84%(+27.4%) |
Dec 2010 | -258.72% | -364.79%(-44.5%) |
Sept 2010 | - | -657.64%(+156.6%) |
Date | Annual | Quarterly |
---|---|---|
June 2010 | - | -256.29%(+361.8%) |
Mar 2010 | - | -55.50%(-83.0%) |
Dec 2009 | -157.61%(-64.0%) | -326.76%(-33.4%) |
Sept 2009 | - | -490.76%(+4975.1%) |
June 2009 | - | -9.67%(-97.0%) |
Mar 2009 | - | -317.60%(+4.7%) |
Dec 2008 | -438.29%(-87.9%) | -303.39%(+3.3%) |
Sept 2008 | - | -293.84%(-51.0%) |
June 2008 | - | -599.22%(-88.9%) |
Mar 2008 | - | -5407.19%(+3323.1%) |
Dec 2007 | -3620.20%(+1027.7%) | - |
Sept 2007 | - | -157.96%(-79.8%) |
June 2007 | - | -780.47%(-74.8%) |
Mar 2007 | - | -3096.07%(>+9900.0%) |
Dec 2006 | -321.02%(-27.4%) | -27.95%(-99.6%) |
Sept 2006 | - | -6591.73%(+308.3%) |
June 2006 | - | -1614.35%(+8.7%) |
Mar 2006 | - | -1485.26%(+13.0%) |
Dec 2005 | -441.93%(+1341.9%) | -1314.18%(+808.6%) |
Sept 2005 | - | -144.63%(-58.4%) |
June 2005 | - | -347.76%(+34.8%) |
Mar 2005 | - | -257.95%(-31.1%) |
Dec 2004 | -30.65%(-53.5%) | -374.65%(+51.4%) |
June 2004 | - | -247.40%(-490.5%) |
Mar 2004 | - | 63.35%(-363.4%) |
Dec 2003 | -65.89%(-53.6%) | -24.05%(-61.4%) |
Sept 2003 | - | -62.27%(-12.2%) |
June 2003 | - | -70.93%(-58.3%) |
Mar 2003 | - | -170.04%(-36.7%) |
Dec 2002 | -141.86%(-28.5%) | -268.69%(+199.1%) |
Sept 2002 | - | -89.82%(+51.7%) |
June 2002 | - | -59.22%(-77.6%) |
Mar 2002 | - | -264.32%(+31.6%) |
Dec 2001 | -198.42%(+43.5%) | -200.90%(+2.8%) |
Sept 2001 | - | -195.43%(-65.4%) |
June 2001 | - | -565.36% |
Dec 2000 | -138.30%(-54.2%) | - |
Dec 1999 | -302.12% | - |
FAQ
- What is the all time high annual net margin for Plus Therapeutics?
- What is the all time high quarterly net margin for Plus Therapeutics?
What is the all time high annual net margin for Plus Therapeutics?
Plus Therapeutics all-time high annual net profit margin is -30.65%
What is the all time high quarterly net margin for Plus Therapeutics?
Plus Therapeutics all-time high quarterly net profit margin is 74.41%